MDGL   $233.86  -3.46% Market Closed After Close 233.49 -0.16%

Madrigal Pharmaceuticals Inc
Last Events:

2023-08-09 Signal in RSI changed from bullish reversal to bearish recovery. RSI indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

2023-08-06 Trend pattern changed from расширяющийся канал to канал.

2023-08-06 Signal in RSI changed from bearish recovery to bullish reversal. RSI indicator is in the lower part of the neutral territory and left the oversold territory. These factors indicate that perhaps the downside trend is coming to an end price will probably head north Last signal: exit from the overbought zone.

2023-08-05 Trend pattern changed from расходящийся клин с наклоном вниз to расширяющийся канал.

2023-08-04 Signal in Stochastic changed from bullish reversal to bearish recovery. The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: main and signal line crossing.

2023-08-04 Signal in MACD changed from bullish reversal to bearish recovery. Oscillator MACD is in the negative territory it crossed the signal line from the top and falls. These factors mean that the market confirms the tendency to fall. Last signal: main and signal line crossing.

2023-08-03 Signal in MACD changed from bearish weakening to bullish reversal. Oscillator MACD is in the negative territory it crossed the signal line from the bottom and grows. These factors mean that the market confirms the end of the downward trend. Last signal: main and signal line crossing.

2023-08-03 Trend Power changed from slow to medium strength.


Current temperature: 2.64
ST: 0, Cor:

50-50 Year Forecast
Low with % probability:
Target: 165.91
High with % probability:
Analyst Recommendations:
Number of estimates 15
Target Price Mean 362.533
Mean unverified/preliminary 362.533 / 362.533
Target Price Low / High 150.000 / 511.000
Median / STD DEV 377.000 / 86.83
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy Buy Sell
rsi Sell Sell Sell
macd None None None
stoch None None None
ma20 ActivelyBuy Buy Sell
ma50 None None None
ma100 None ActivelyBuy None
Candlestick PatternSept. 11, 2024 Deliberation Block Formation - consists of three black bodies with consecutively lower closes in a downtrend. The final day is a short black candlestick, a spinning top or a doji. Considered to be a bullish reversal pattern.
ISIN US5588681057
ceo Mr. William J. Sibold
Website https://www.madrigalpharma.com
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.